source
- Vertex renews partnership with Genomics in up to $220 million, four-year extensionVertex Pharmaceuticals has extended its collaboration with sequencing specialist Genomics, signing a new agreement that can be worth up to $220 million. The extension adds four more years to the e…
- Mount Sinai researchers map enzyme structure linked to rare metabolic disorder GA1Researchers at Icahn School of Medicine at Mount Sinai have determined the crystal structure of an upstream enzyme involved in glutaric aciduria type 1 (GA1), a rare neuro‑metabolic disease. GA1 r…